A critical advance in cancer research is arising with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently disabled in various forms of cancer, causing uncontrolled https://wildbookmarks.com/story22154210/vhh-fragments-reactivate-tumor-suppressor-p53-the-promising-pathway-for-cancer-therapy